Insider Trading Activity For Anavex Life Sciences Corp. (NASDAQ:AVXL)
Christopher U Missling , CEO of Anavex Life Sciences Corp. (NASDAQ:AVXL) reportedly Bought 1,650 shares of the company’s stock at an average price of 2.41 for a total transaction amount of $3,976.50 SEC Form
Insider Trading History For Anavex Life Sciences Corp. (NASDAQ:AVXL)
On 6/4/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.37 per share and the total transaction amounting to $370.00.
On 6/8/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.35 per share and the total transaction amounting to $350.00.
On 6/10/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.36 per share and the total transaction amounting to $360.00.
On 6/15/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.43 per share and the total transaction amounting to $430.00.
On 6/16/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.44 per share and the total transaction amounting to $440.00.
On 6/22/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.42 per share and the total transaction amounting to $420.00.
On 6/23/2015 Christopher U Missling, CEO, bought 1,000 with an average share price of $0.47 per share and the total transaction amounting to $470.00.
Analyst Ratings History For Anavex Life Sciences Corp. (NASDAQ:AVXL)
- On 10/5/2016 FBR & Co Reiterated Rating Outperform with a price target of $10.00
- On 2/14/2018 Maxim Group Set Price Target of rating Buy with a price target of $5.00
- On 2/21/2018 Noble Financial Reiterated Rating Buy
Recent Trading Activity for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Shares of Anavex Life Sciences Corp. closed the previous trading session at with 2.380000114440918 shares trading hands.